fluorobenzenes has been researched along with Chronic Illness in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askevold, ET; Aukrust, P; Gravning, J; Gullestad, L; Kjekshus, J; McMurray, JJ; Nymo, SH; Ueland, T; Wikstrand, J | 1 |
| Böhm, M; Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez, AC; Pocock, SJ; Rogers, JK; van Veldhuisen, DJ; Wedel, H; Wikstrand, J | 1 |
| Barlera, S; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Tavazzi, L; Tognoni, G | 1 |
| Hoppe, UC; Nitschmann, S | 1 |
| Andreou, I; Antoniades, C; Charakida, M; Gounari, P; Kotrogiannis, I; Miliou, A; Papageorgiou, N; Stefanadis, C; Tentolouris, C; Tousoulis, D; Trikas, A | 1 |
| Cosmi, F; Fabbri, G; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Stefanelli, S; Tavazzi, L; Tognoni, G | 1 |
| Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
| Andreou, I; Dimopoulos, MA; Gounari, P; Miliou, A; Papadimitriou, CA; Papageorgiou, N; Siasos, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Zisimos, K | 1 |
| Ashton, E; Krum, H; Reid, C; Rosenfeldt, F; Schneider, H; Skiba, M; Tonkin, A; Windebank, E | 1 |
| Adams, V; Beck, EB; Erbs, S; Gielen, S; Hambrecht, R; Höllriegel, R; Kränkel, N; Linke, A; Möbius-Winkler, S; Schuler, G; Thiele, H | 1 |
| Aukrust, P; Böhm, M; Dahl, CP; Goudev, A; Gullestad, L; Hulthe, J; Kjekshus, J; Lindberg, M; Mach, F; Ueland, T; Wikstrand, J | 1 |
| Furr, A; Lapiz-Bluhm, MD; Morilak, DA | 1 |
| Askevold, ET; Aukrust, P; Flo, TH; Gullestad, L; Hulthe, J; Kjekshus, J; McMurray, J; Nymo, SH; Ueland, T; Van Veldhuisen, DJ; Wikstrand, J; Yndestad, A | 1 |
| Auleley, GR; Boutron, I; Konrat, C; Ravaud, P; Ricordeau, P; Trinquart, L | 1 |
| Bo, H; Deng, J; Deng, W; Huang, NW; Wang, DX; Zhang, W; Zhu, T | 1 |
| Aukrust, P; Bottazzi, B; Cuccovillo, I; Gullestad, L; Latini, R; Lucci, D; Mantovani, A; Masson, S; Masuda, N; Nymo, SH; Sudo, Y; Tavazzi, L; Tognoni, G; Ueland, T; Vårdal, M; Wikstrand, J | 1 |
| Bauersachs, J; Eigenthaler, M; Ertl, G; Firnschild, A; Fraccarollo, D; Frantz, S; Schäfer, A; Tas, P | 1 |
| Amarena, J; Ashton, E; Kalff, V; Krum, H; Reid, C; Rogers, J; Singh, B; Tonkin, A | 1 |
| Ahmadi, S; Brockhaus, J; Brune, K; Fritschy, JM; Hess, A; Hösl, K; Knabl, J; Möhler, H; Reinold, H; Rudolph, U; Sergejeva, M; Witschi, R; Zeilhofer, HU; Zeilhofer, UB | 1 |
| Mareev, VIu | 1 |
| Gollerkeri, MP; Madyastha, KR; Prema, S; Sahasrabudhe, MB | 1 |
| Benson, K; Gálfi, B; Grynaeus, T | 1 |
| Angst, J; Frei, M | 1 |
| Malm, U; Perris, C; Rapp, W; Wedrén, G | 1 |
| Singh, AN | 1 |
17 trial(s) available for fluorobenzenes and Chronic Illness
| Article | Year |
|---|---|
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sensitivity and Specificity; Stroke; Sulfonamides; Survival Rate; Troponin T | 2014 |
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Topics: Aged; Chronic Disease; Epidemiologic Methods; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides | 2014 |
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Proportional Hazards Models; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2008 |
Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Topics: Aged; Allopurinol; Biomarkers; Chronic Disease; Drug Therapy, Combination; Extracellular Matrix; Female; Fluorobenzenes; Free Radical Scavengers; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2010 |
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2009 |
Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.
Topics: Adiponectin; Aged; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Glycated Hemoglobin; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.
Topics: Aged; Allopurinol; Biomarkers; Cholesterol; Cholesterol, LDL; Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Peroxidase; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2010 |
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
Topics: Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.
Topics: Administration, Oral; Aged; Cells, Cultured; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Fluorobenzenes; Heart Failure; Humans; Male; Middle Aged; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Europe; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Osteoprotegerin; Predictive Value of Tests; Proportional Hazards Models; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2011 |
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
Topics: Acute-Phase Proteins; Aged; Apolipoprotein A-I; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fluorobenzenes; Glomerular Filtration Rate; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipocalin-2; Lipocalins; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Norway; Patient Readmission; Peptide Fragments; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides | 2012 |
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Topics: Aged; C-Reactive Protein; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Prognosis; Proportional Hazards Models; Pyrimidines; Risk Assessment; Rosuvastatin Calcium; Serum Amyloid P-Component; Sulfonamides | 2012 |
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
Topics: Adult; Aged; Chronic Disease; Cytokines; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neurotransmitter Agents; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Remodeling | 2007 |
[Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].
Topics: Aged; Aged, 80 and over; Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Russia; Stroke Volume; Sulfonamides; Survival Rate; Treatment Outcome | 2008 |
[Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
Topics: Adult; Attention; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Fluorobenzenes; Galvanic Skin Response; Humans; Memory; Motor Skills; Occupational Therapy; Perception; Piperidines; Placebos; Schizophrenia; Spiro Compounds; Tranquilizing Agents; Word Association Tests | 1973 |
[The depot neuroleptic agent fluspirilene (author's transl)].
Topics: Basal Ganglia Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Female; Fluorobenzenes; Fluphenazine; Heart Rate; Humans; Injections, Intramuscular; Male; Parkinson Disease, Secondary; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Spiro Compounds; Time Factors; Tranquilizing Agents | 1973 |
A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
Topics: Adult; Caproates; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Female; Fluorobenzenes; Fluphenazine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paranoid Disorders; Piperidines; Psychiatric Status Rating Scales; Psychological Tests; Schizophrenia; Spiro Compounds; Time Factors | 1974 |
8 other study(ies) available for fluorobenzenes and Chronic Illness
| Article | Year |
|---|---|
[Rosuvastatin in patients with chronic heart failure].
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Proportional Hazards Models; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2009 |
5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Attention; beta-Cyclodextrins; Chronic Disease; Citalopram; Cognition; Fluorobenzenes; Male; Microinjections; Pharmaceutical Vehicles; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Reversal Learning; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Set, Psychology; Stress, Psychological | 2012 |
Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Chronic Disease; Etidronic Acid; Fluorobenzenes; France; Humans; Middle Aged; Pioglitazone; Prescription Drugs; Pyrimidines; Randomized Controlled Trials as Topic; Risedronic Acid; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Thiazolidinediones; Valine; Valsartan | 2012 |
Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.
Topics: Animals; Asthma; Chronic Disease; Disease Models, Animal; Female; Fluorobenzenes; GABA-A Receptor Antagonists; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Mice; Mice, Inbred BALB C; Mucus; Pyrimidines; Receptors, GABA-A; Rosuvastatin Calcium; Sulfonamides | 2012 |
Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Topics: Animals; Cell Adhesion Molecules; Chronic Disease; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microfilament Proteins; Myocardial Infarction; Nitric Oxide; Phosphoproteins; Phosphorylation; Platelet Activation; Pyrimidines; Rats; Reactive Oxygen Species; Rosuvastatin Calcium; Sulfonamides; Superoxides; Thrombosis; Vasoconstriction; Vasodilation; Ventricular Function, Left | 2005 |
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
Topics: Analgesics; Animals; Brain; Capsaicin; Chronic Disease; Diazepam; Disease Models, Animal; Fluorobenzenes; Formaldehyde; Ganglia, Spinal; Hot Temperature; Inflammation; Male; Mice; Neurons; Organ Specificity; Pain; Protein Isoforms; Protein Subunits; Rats; Rats, Wistar; Receptors, GABA-A; Spinal Cord; Triazoles | 2008 |
Some observations on the use of chemically labelled normal white blood cells as antigens in active immunization of leukaemia.
Topics: Antibody Formation; Antibody Specificity; Blood Cell Count; Chronic Disease; Complement System Proteins; Fluorobenzenes; Humans; Immunity, Active; Immunotherapy; Injections, Intramuscular; Isoantibodies; Leukemia, Myeloid; Leukocytes; Remission, Spontaneous | 1974 |
Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Evaluation Studies as Topic; Female; Fluorobenzenes; Humans; Injections, Intramuscular; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Social Adjustment; Spiro Compounds; Tranquilizing Agents | 1973 |